Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes.
about
Current status and patent prospective of animal models in diabetic researchNew experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathyLaboratory animals as surrogate models of human obesity.Mouse models of diabetic nephropathy.Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus.Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice.The use of animal models in diabetes research.microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.Animal models of diabetic uropathy.Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition.Obesity and asthma: lessons from animal models.Advances in murine models of diabetic nephropathy.Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice.Animal models of wound healing: utility in transgenic mice.Control of diabetic hyperglycaemia and insulin resistance through TSC22D4.Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes.Tacrolimus in the prevention of adverse pregnancy outcomes and diabetes-associated embryopathies in obese and diabetic mice.A review of rodent models of type 2 diabetic skeletal fragility.Mouse models of diabetic neuropathy.Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJUnravelling the stromal-nerve interactions in the human diabetic cornea.Influence of Chronic Exposure to Simulated Shift Work on Disease and Longevity in Disease-Prone Inbred Mice.NOD1 receptor is up-regulated in diabetic human and murine myocardium.Multidimensional genome scans identify the combinations of genetic loci linked to diabetes-related phenotypes in mice.
P2860
Q26799371-959925A6-B434-4F74-8547-21FB8C8369E3Q26996084-C9CC173F-10F9-4E18-A62E-C57CA177F816Q33567304-959316B1-B725-4305-9741-A65B150A5E22Q33821186-92B66735-4605-4500-9065-7232C648639BQ33924273-9240FA1F-58FD-482C-ACB6-4F62077E8963Q34036610-5A9EE8D7-B9D4-4C52-9832-5B8FBF2A6B86Q34238362-40094B05-D4F8-4692-AEAF-733F52BF1370Q34255921-551B2ECC-A8B2-4A62-9579-B764D868BA94Q35116623-88EA55E6-D946-46DF-85B9-B560BFDB6AAAQ35220587-261D90EF-38BB-4C49-A275-64D7E1EC0897Q36047572-FB6DE940-093F-46D7-B5B9-11036F1B1EBEQ36423648-F68C67C1-417E-4B27-8681-0DB28BD8B9CFQ36521097-2FD9D636-28A9-4A23-910E-FA97C1C0555AQ36629058-4969C37A-1BF1-4206-96F0-A91BA2E2CDDFQ36971495-9A85DE27-74FA-42B4-A348-4A3230A3706EQ37163486-CA4DFA46-BCFF-4B1D-938F-843B2C736881Q37222816-34A5CB92-5D9C-4943-BEAF-393B3B16A7B5Q37408625-A48C3C18-785A-4B6E-AFF7-5369BD76FF48Q37538274-9A022EEB-468E-49B1-9263-758BA14DA068Q37640553-AE168317-AC3B-4217-9091-F789C329693FQ37650212-CCC0EE5E-537E-4D4D-8099-73C200910C05Q37655239-631BB346-DC24-4561-B4DA-95EFBDD610E7Q38106718-4F2E312D-3BFE-4CFE-9024-7525B29EEE0FQ38615682-C32AB239-43ED-45EF-A9BA-C6A5A122A5FDQ38851805-93CFB1D8-BDCD-47C8-9A17-5D93BAA76569Q38984265-5A2F64DC-0B82-4685-BD0C-5D4F74807BECQ46830876-93B3FD0C-7576-422F-8CB2-F4315C631E55
P2860
Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Differential levels of diabeto ...... f obesity and type 2 diabetes.
@ast
Differential levels of diabeto ...... f obesity and type 2 diabetes.
@en
type
label
Differential levels of diabeto ...... f obesity and type 2 diabetes.
@ast
Differential levels of diabeto ...... f obesity and type 2 diabetes.
@en
prefLabel
Differential levels of diabeto ...... f obesity and type 2 diabetes.
@ast
Differential levels of diabeto ...... f obesity and type 2 diabetes.
@en
P1433
P1476
Differential levels of diabeto ...... f obesity and type 2 diabetes.
@en
P2093
Edward H Leiter
Peter C Reifsnyder
P356
10.2337/DIABETES.53.2007.S4
P407
P478
53 Suppl 1
P577
2004-02-01T00:00:00Z